Skip to main content

StateHouse Holdings Inc. (STHZF)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
40.8Fair

ValueMarkers Composite Index

Top 7%#41,384 of 44,707

DCF data not available

Piotroski
5/9
Neutral
Beneish
-3.41
Low Risk
Altman
-5.65
Distress
DCF Value
-
N/A
ROIC
4.1%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

StateHouse Holdings Inc. (STHZF) — VMCI valuation read

Headline read on STHZF: VMCI of 41/100 versus a Healthcare sector median of 50. The 9-point below-median position is what makes StateHouse Holdings Inc. a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on STHZF: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on STHZF: value (STHZF trades at 19.0x earnings, 6% above the Healthcare median of 18.0x), quality (ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of 1.3x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.

STHZF fell 3.4% over the trailing 7 days, with a -18.3% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in STHZF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.